Single-Use Duodenoscope Market Global Report 2026

The single-use duodenoscope market size has grown rapidly in recent years. It will grow from $0.59 billion in 2025 to $0.68 billion in 2026 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to growing incidence of bile duct and pancreatic disorders, rising hospital-acquired infection concerns linked to reusable scopes, expansion of endoscopic retrograde cholangiopancreatography procedures, increased adoption of minimally invasive surgical techniques, improvements in hospital endoscopy infrastructure.

The single-use duodenoscope market size is expected to see rapid growth in the next few years. It will grow to $1.17 billion in 2030 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to increasing shift toward single-use medical devices for infection prevention, rising healthcare expenditure and procedural volumes in gastroenterology, technological advancements in disposable endoscope imaging quality, expanding ambulatory surgery centers and outpatient care adoption, stricter global regulatory standards for cross-contamination control. Major trends in the forecast period include rising adoption of single-use duodenoscopes to reduce hospital-acquired infections, increasing preference for sterile disposable endoscopy devices in ercp procedures, growth in demand for high-precision minimally invasive gastrointestinal diagnostics, expansion of outpatient and ambulatory endoscopy services, rising regulatory pressure for infection control in reusable endoscope alternatives.

The rising prevalence of healthcare-acquired infections is expected to drive the growth of the single-use duodenoscope market going forward. Healthcare-associated infections (HAIs) refer to infections that patients develop during the course of receiving treatment in a healthcare facility, which were not present at the time of admission. Healthcare-associated infections are increasing primarily due to the growing use of invasive medical devices, which can introduce infections into the body if not properly sterilized or handled. Single-use duodenoscopes help reduce healthcare-associated infections by removing the need for reprocessing and sterilization between patients, thereby eliminating the risk of cross-contamination from inadequately disinfected reusable scopes. For instance, in September 2024, according to the UK Health Security Agency, a UK-based government agency, in the fiscal year 2022-2023, the total number of hospital-onset healthcare-associated (HOHA) E. coli infections rose from 6,525 to 7,881 cases. Therefore, the rising prevalence of healthcare-acquired infections is driving the growth of the single-use duodenoscope market.

The increasing burden of gastrointestinal disorders is expected to drive the growth of the single-use duodenoscope market going forward. Gastrointestinal disorders are conditions that affect the digestive system, disrupting normal digestion, nutrient absorption, and bowel function. Gastrointestinal disorders are rising mainly due to unhealthy diets high in processed and low-fiber foods, which impair digestion and gut health. Single-use duodenoscopes assist in gastrointestinal disorders by enabling accurate diagnosis and treatment of bile and pancreatic duct conditions while reducing infection risks associated with reusable devices. For instance, in December 2023, according to the IBD Registry, a UK-based nonprofit organization, by 2023, the number of individuals with inflammatory bowel disease (IBD) exceeded 5,300, representing an increase of more than 3,000 members compared to the previous year (2022). Therefore, the increasing burden of gastrointestinal disorders is driving the growth of the single-use duodenoscope market.

Leading operating in the single-use duodenoscope market are focusing on developing innovative solutions, such as new-generation duodenoscopy systems, to enhance patient safety by eliminating cross-contamination risks, reducing healthcare-associated infections, and improving procedural efficiency in endoscopic procedures. A new-generation duodenoscopy system is an advanced endoscopy technology designed to improve visualization, safety, and infection control during duodenal procedures, often incorporating single-use or enhanced reprocessing features. For example, in April 2024, Ambu A/S, a Denmark-based medical technology company, received a 510(k) clearance from the US FDA for its new-generation duodenoscopy solution, the aScope Duodeno 2 and aBox 2, designed specifically for endoscopic retrograde cholangiopancreatography (ERCP) procedures. This sterile, single-use system addresses key challenges in ERCP, including high-performance needs and the burdens of complex reprocessing for reusable duodenoscopes.

Major companies operating in the single-use duodenoscope market are Medtronic Plc, Fujifilm Holdings Corporation, Boston Scientific Corporation, Olympus Corporation, Hoya Corporation, Karl Storz SE & Co. KG, PENTAX Medical, Ambu A/S, Shenzhen Hugemed Medical Technology Development Co. Ltd., Ottomed Medical Technologies Pvt. Ltd., EndoFresh, Micro-Tech (Nanjing) Co. Ltd.

North America was the largest region in the single-use duodenoscope market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the single-use duodenoscope market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the single-use duodenoscope market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The single-use duodenoscope market consists of sales of disposable duodenoscope systems, sterile duodenoscopy kits, and therapeutic single-use duodenoscopes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.